SIS
APGE icon

Sound Income Strategies’s Apogee Therapeutics APGE Stock Holding History

Sound Income Strategies’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51
Closed -$4.3K – 578
2026
Q1 		$4.3K Buy
+51
New +$3.7K ﹤0.01% 1895

Other funds holding APGE

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOAM
SBI Okasan Asset Management Tokyo, Japan $3.04B AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Sound Income Strategies's APGE Position: Q2 2026 in Review

Sound Income Strategies sold out of Apogee Therapeutics (APGE) in Q2 2026, closing a stake of 51 shares — an estimated $4.3K sold.

Sound Income Strategies first reported a position in APGE in Q1 2026 and held it in 1 quarter. The position peaked at $4.3K in Q1 2026. 25 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Sound Income Strategies reported no remaining Apogee Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 51 Apogee Therapeutics shares in Q2 2026, an estimated $4.3K.
  • Sound Income Strategies first reported a position in Apogee Therapeutics in Q1 2026 and held it in 1 quarter.
  • Sound Income Strategies's Apogee Therapeutics position peaked at $4.3K in Q1 2026.
  • 25 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.